Search

Displaying results 3371 - 3380 of 4859 in total

Drug
GS030-DP
go.drugbank.com/drugs/DB17847
Investigational
It is a component of GS030, an investigational optogenetic treatment, in combination with a medical device GS030-MD.[A259816, L46701] … It targets retinal ganglion cells that encodes a light-sensitive channelrhodopsin, ChrimsonR-tdTomato (ChR-tdT), delivered by an AAV2.7m8 vector.
Drug
PGX-100
go.drugbank.com/drugs/DB06114
Investigational
It is a nearly nonanticoagulant heparin derivative that retains its anti-inflammatory activity. … It is developed for treatment of exacerbation of obstructive pulmonary disease (COPD) and for the prevention and treatment of cardiac ischemia reperfusion injury (following acute myocardial infarction
Drug
Tipifarnib
go.drugbank.com/drugs/DB04960
Investigational
It belongs to the family of drugs called farnesyltransferase inhibitors. It is also called Zarnestra. In June 2005, the FDA issued a Not Approvable Letter for Zarnestra.
Drug
IDD-3
go.drugbank.com/drugs/DB05427
Experimental
It consists of mature dendritic cells loaded with lysates from melanoma tumor cell lines. … It includes Dendritophages that are dendritic cells, a type of specialized immune cells derived from the patient's own white blood cells.
Drug
CTR-107
go.drugbank.com/drugs/DB18583
Experimental
It is being investigated for the treatment of familial exudative vitreoretinopathy.
Drug
Ninvosudil
go.drugbank.com/drugs/DB08756
Investigational
It inhibits calcium sensitization to affect smooth muscle relaxation.
Drug
NS-398
go.drugbank.com/drugs/DB14060
Experimental
It was developed as part of the mechanistic study of the cyclooxygenases.
Drug
Dasiprotimut-T
go.drugbank.com/drugs/DB17287
Experimental
[A254701] It has been investigated in clinical trials.
Drug
E59
go.drugbank.com/drugs/DB18372
Experimental
It was developed by Sixal Inc.
Drug
MaaT013
go.drugbank.com/drugs/DB18648
Investigational
It is being investigated for the treatment of Graft-Versus-Host Disease.